M. Kwong

Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats.

I. Goldberg, K. Wasan, T. Johnston, 2003, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Cyclosporine Binds to the Neutral Lipid and Potentially Other Binding Sites of Lipid Transfer Protein I

K. Wasan, M. Kwong, 2003, Pharmaceutical Research.

Cholesteryl ester transfer protein facilitates the movement of water-insoluble drugs between lipoproteins: a novel biological function for a well-characterized lipid transfer protein.

K. Wasan, M. Kwong, 2002, Biochemical pharmacology.

Assessing plasma lipid levels, body weight, and hepatic and renal toxicity following chronic oral administration of a water soluble phytostanol compound, FM-VP4, to gerbils.

K. Wasan, P. Pritchard, M. Kwong, 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

The influence of lipid transfer protein I on the binding and transfer of cyclosporine A between lipoproteins

M. Kwong, 2002 .

Role of plasma lipoproteins in modifying the toxic effects of water-insoluble drugs: Studies with cyclosporine A

K. Wasan, M. Ramaswamy, M. Kwong, 2008, AAPS PharmSci.

Cyclosporine A transfer between high- and low-density lipoproteins: independent from lipid transfer protein I-facilitated transfer of lipoprotein-coated phospholipids because of high affinity of cyclosporine a for the protein component of lipoproteins.

K. Wasan, O. Sivak, E. Kwong, 2001, Journal of pharmaceutical sciences.

Blood and plasma lipoprotein distribution and gender differences in the plasma pharmacokinetics of lipid-associated annamycin.

K. Wasan, M. Kwong, 1997, Pharmacology & toxicology.